HIV Vaccine May Cut Infection Rate
After almost 30 years since HIV surfaced in the United States, researchers in Thailand and the U.S. have created an experimental vaccine that has, over a seven-year study, been found to reduce the risk of contracting HIV by one-third. The vaccine is a combination of two existing vaccinations that were not successful in reducing infection.
After almost 30 years since HIV surfaced in the United States, researchers in Thailand and the U.S. have created an experimental vaccine that has, over a seven-year study, been found to reduce the risk of contracting HIV by one-third. The vaccine is a combination of two existing vaccinations that were not successful in reducing infection. — JCL
WAIT BEFORE YOU GO...The Guardian:
An experimental HIV vaccine has for the first time cut the risk of infection, researchers say.
A medical trial in Thailand has raised hopes of a major breakthrough in the fight against Aids after scientists said an experimental vaccine had reduced the risk of HIV infection by a third.
The world’s largest HIV/Aids vaccine trial of more than 16,000 volunteers was the first in which infection has been prevented, according to the US army, which sponsored the trial with the National Institute of Allergy and Infectious Diseases.
A combination of two vaccines was tested on HIV-negative Thai men and women aged 18 to 30 at average risk of becoming infected. All the volunteers were given counselling and condoms to help them avoid HIV. Then half were randomly picked to receive the vaccine, while the other half got dummy shots. Until the trial ended, nobody knew who had been given the genuine vaccine and who had not.
This year, the ground feels uncertain — facts are buried and those in power are working to keep them hidden. Now more than ever, independent journalism must go beneath the surface.
At Truthdig, we don’t just report what's happening — we investigate how and why. We follow the threads others leave behind and uncover the forces shaping our future.
Your tax-deductible donation fuels journalism that asks harder questions and digs where others won’t.
Don’t settle for surface-level coverage.
Unearth what matters. Help dig deeper.
Donate now.
Film
A documentary tells the story of Carl Bean, a disco star who preached the gospel of love and acceptance at the height of the AIDS crisis.
Health & Wellness
A disruption in federal funds has jeopardized HIV testing and outreach in Mississippi, and researchers warn of a resurgence of the epidemic in the South.
Health & Wellness
Aging with HIV comes with an increased risk of health complications later in life. Is the U.S. health care system prepared to treat this growing population?
Opinion
A HIV survivor and former instructor reflects on his experiences.
The 40th president, though he proved to be less extreme than his campaign promises, ignited a wide transformation that resounds to this day.
In 2017, almost 16,000 people died from complications of the virus.
You need to be a supporter to comment.
There are currently no responses to this article.
Be the first to respond.